L. De Leval

Discipline

Economies et finances (12) Psychologie (6) Histoire, Philosophie et Sociologie des sciences (3) Linguistique (2) Sciences de l'information et de la communication (2) Sociologie (1) Géographie (1) Archéologie et Préhistoire (1)

Type de document

Articles (105) Recensions (15) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Lymphomas (64) Human beings (54) Cases (36) Cases (36) Treatment (30) maladie (29) Patients (29) Expression (29) Patients (29) maladie (29) Cells (28) Tumors (19) survie (17) Survival (17) Analysis (17) tissu (corporel) (16) analyse (16) Diagnosis (16) Diseases (16) Example (16) Diseases (16) Diagnosis (16) Case (15) Genes (15) Therapeutics (15) T cells (15) Prognosis (15) Immunohistochemistry (15) Grammar, Comparative and general--Case (15) Case (15)

Documents écrit par L. De Leval (105) | parle de L. De Leval (0)

Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
E. Poullot et al.
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
B. Bisig et al. (1 déc. 2023)
Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization.
K.J. Savage et al. (1 déc. 2023)
Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen? [What is new in the classification of peripheral T cell lymphomas?]
L. de Leval et al.
Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism ratio.
M. Straub et al. (13 nov. 2023)
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
A. Decroos et al. (1 oct. 2023)
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
P. Hofman et al.
Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
A. Di Napoli et al.
Correction to: Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
A. Di Napoli et al.
Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
F. Climent et al.
Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
A. Zamò et al.
The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
A. Zamò et al.
Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
S.L. Ondrejka et al.
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
L. Quintanilla-Martinez et al.
Multilevel human secondary lymphoid immune system compartmentalization revealed by complementary imaging approaches.
B.L. Oyler et al. (18 août 2023)
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
J. Leca et al. (13 févr. 2023)
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells.
V. Joo et al. (2023)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
L. Veloza et al. (1 janv. 2023)
Extranodal T- and NK-cell lymphomas.
L. de Leval et al.
Towards a national strategy for digital pathology in Switzerland.
A. Janowczyk et al.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
E. Campo et al. (15 sept. 2022)
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.
K. Evangelou et al.
The EHA Research Roadmap: Malignant Lymphoid Diseases.
M. Dreyling et al.
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
A. Ségot et al. (1 mars 2022)
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
L. Veloza et al.

next